Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression

Biological Psychiatry

Volumn 58, Issue 12, 2005, Pages 963-968

  O'Keane, Veronica ^a   Dinan, Ted G ^c   Scott, Lucinda ^c   Corcoran, Ciaran ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Chronic depression; HPA axis; Vagus nerve stimulation therapy

Indexed keywords

ALPRAZOLAM; AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROMAZEPAM; CARBAMAZEPINE; CLOMIPRAMINE; CORTICOTROPIN RELEASING FACTOR; DOSULEPIN; LITHIUM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; PAROXETINE; PHENELZINE; RISPERIDONE; SERTRALINE; TEMAZEPAM; TRANYLCYPROMINE; VENLAFAXINE; ZOPICLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NERVE STIMULATION; PRIORITY JOURNAL; VAGUS NERVE;

ADRENOCORTICOTROPIC HORMONE; ADULT; CHRONIC DISEASE; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PSYCHOTROPIC DRUGS; VAGUS NERVE;

EID: 29044451028     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.04.049     Document Type: Article

References (42)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) 2004 American Psychiatric Association Washington, DC
2. M.C. Austin, J.E. Janosky, H.A. Murphy Increased corticotrophin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men Mol Psychiatry 8 2003 324 332
3. F. Benazzi Chronic atypical major depressive episode in private practice Unipolar and bipolar II Acta Psychiatr Scand 100 1999 418 423
4. E. Ben-Menachem, A. Hamberger, T. Hedner, E.J. Hammond, B.M. Uthman, J. Slater Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures Epilepsy Res 20 1999 221 227
5. S. Bhatnagar, C. Vining Facilitation of hypothalamic-pituitary-adrenal responses to novel stress following repeated social stress using the resident/intruder paradigm Horm Behav 43 2003 158 165
6. R. Catalan, J.M. Gallart, J.M. Castellanos, R. Galard Plasma corticotrophin-releasing factor in depressive disorders Biol Psychiatry 44 1998 15 20
7. S.J. Claes Corticotropin-releasing hormone (CRH) in psychiatry From stress to psychopathology Ann Med 36 2004 50 61
8. A.J. Cleare, E. Heap, G.S. Mahli, S. Wessley, V. O'Keane, J. Miell Low-dose hydrocortisone in chronic fatigue syndrome A randomised cross-over trial Lancet 353 1999 455 458
9. C. Corcoran, T.G. Connor, V. O'Keane, M. Garland The effect of vagus nerve stimulation on peripheral pro- and anti-inflammatroy cytokines in humans Eur Arch Psychiatry Clin Neurosci 253 2003 259
10. C.M. DeGiorgio, S.C. Schachter, A. Handforth, M. Salinsky, J. Thompson, B. Uthman Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures Epilepsia 41 2000 1195 1200
11. M.A. Demitrack, L.J. Crofford Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome Ann N Y Acad Sci 840 1998 684 697
12. T.G. Dinan, S. O'Brein, E. Lavelle, L.V. Scott Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression Psychol Med 34 2004 169 172
13. L.D. Dorn, E.S. Burgess, T.C. Friedman, B. Dubbert, P.W. Gold, G.P. Chrousos The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism J Clin Endocrinol Metab 82 1997 912 919
14. G. Elger, C. Hoppe, P. Falkai, A.J. Rush, C.E. Elger Vagus nerve stimulation is associated with mood improvements in epilepsy patients Epilepsy Res 42 2000 203 210
15. M.S. George, Z. Nahas, D.E. Bohning, F.A. Kozel, B. Anderson, J.H. Chae Vagus nerve stimulation therapy A research update Neurology 59 2002 S56 S61
16. M.L. Gilmor, K.H. Skelton, C.B. Nemeroff, M.J. Owens The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotrophin-releasing factor neuronal systems J Pharmacol Exp Ther 305 2003 434 439
17. P.W. Gold, J. Licinio, M.-L. Wong, G.P. Chrousos Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs Ann N Y Acad Sci 771 1995 716 729
18. E.N. Griep, J.W. Boersma, E.R. de Kloet Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome J Rheumatol 20 1993 469 474
19. C. Heim, D.J. Newport, R. Bonsall, A.H. Miller, C.B. Nemeroff Altered pituitary-adrenal axis responses to provocative challenge test adult survivors of childhood abuse Am J Psychiatry 158 2001 575 581
20. I. Heuser, G. Bissette, M. Dettling, U. Schweiger, U. Gotthardt, J. Schmider Cerebrospinal fluid concentrations of corticotrophin-releasing hormone vasopressin, and somatostatin in depressed patients and healthy controls Response to amitriptyline treatment Depress Anxiety 8 1998 71 79
21. F. Holsboer High-quality antidepressant discovery by understanding stress hormone physiology Ann N Y Acad Sci 1007 2003 394 404
22. T. Hosoi, Y. Okuma, Y. Nomura Electrical stimulation of afferent vagus nerve induces IL-beta expression in the brain and activates HPA axis Am J Physiol Regul Integr Comp Physiol 279 2000 141 147
23. D. Hucks, S. Lowther, M.R. Crompton, C.L. Katona, R.W. Horton Corticotropin-releasing factor binding sites in cortex of depressed suicides Psychopharmacology 134 1997 174 178
24. J. Kaufman, B. Birmaher, J. Perel, R.E. Dahl, P. Moreci, B. Nelson The corticotrophin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children Biol Psychiatry 42 1997 669 679
25. M.A. Kling, T.D. Geracioti, J. Licinio, D. Michelson, E.H. Oldfield, P.W. Gold Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression preliminary findings Psychopharmacol Bull 30 1994 489 494
26. L.B. Marangell, A.J. Rush, M.S. George, H.A. Sackheim, C.R. Johnson, M.M. Husain Vagus nerve stimulation (VNS) for major depressive episode One year outcomes Biol Psychiatry 15 2002 280 287
27. O. Marti, A. Gavalda, F. Gomez, A. Armario Direct evidence for chronic stress-induced facilitation of the adrenocorticotropin response to a novel acute stressor Neuroendocrinology 60 1994 1 7
28. D.K. Naritoku, W.J. Terry, R.H. Helfert Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve Epilepsy Res 22 1995 53 62
29. D.J. Newport, C. Heim, M.J. Owens, J.C. Ritchie, C.H. Ramsey, R. Bonsall Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test A multiple regression analysis Neuropsychopharmacology 28 2003 569 576
30. C.M. Pariante, A.H. Miller Glucocorticoid receptors in major depression Relevance to pathophysiology and treatment Biol Psychiatry 49 2001 391 404
31. K.J. Parker, A.F. Schatzberg, D.M. Lyons Neuroendocrine aspects of hypercortisolism in major depression Horm Behav 43 2003 60 66
32. F.N. Pitts Jr, C.W. Patterson Electroconvulsive therapy for iatrogenic hypothalamic-hypopituitarism (CRF-ACTH type) Am J Psychiatry 136 1979 1074 1077
33. F.C. Raadsheer, W.J.G. Hoogendijk, F.S. Stam, F.J. Tilders, D.F. Swaab Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients Neuroendocrinology 60 1994 436 444
34. A.M. Rasmusson, D.S. Lipschitz, S. Wang, S. Hu, D. Vojvoda, J.D. Bremner Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder Biol Psychiatry 50 2001 965 977
35. A.J. Rush, M.S. George, H.A. Sackeim, L.B. Marangell, M.M. Husain, C. Giller Vagus nerve stimulation (VNS) for treatment-resistant depressions A multicenter study Biol Psychiatry 47 2000 276 286
36. H.A. Sackheim, A.J. Rush, M.S. George, L.B. Marangell, M.M. Husain, Z. Nahas Vagus nerve stimulation (VNS) for treatment-resistant depression Efficacy, side effects, and predictors of outcome Neuropsychopharmacology 25 2001 713 728
37. M.A. Smith, J. Davidson, J.C. Ritchie, H. Kudler, S. Lipper, P. Chappell, C.B. Nemeroff The corticotrophin-releasing hormone test in patients with posttraumatic stress disorder Biol Psychiatry 26 1989 349 355
38. J.W. Stewart, P.J. McGrath, F.M. Quitkin, W. Harrison, J. Markowitz, S. Wa Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo Arch Gen Psychiatry 46 1989 1080 1087
39. J.W. Stewart, P.J. McGrath, F.M. Quitkin, J.G. Rabkin, W. Harrison, S. Wa Chronic depression Response to placebo, imipramine, and phenelzine J Clin Psychopharmacol 13 1993 391 396
40. S. Watson, P. Gallagher, D. Del-Estal, A. Hearn, I.N. Ferrier, A.H. Young Hypothalamic-pituitary-adrenal axis function in patients with chronic depression Psychol Med 32 2002 1021 1028
41. K. Vonck, P. Boon, K. Van Laere, M. D'Have, T. Vandekerckhove, S. O'Connor Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy Epilepsia 41 2000 601 609
42. E. Widerlov, G. Bissette, C.B. Nemeroff Monoamine metabolites, corticotrophin releasing factor and somatostas as CSF markers in depressed patients J Affect Disord 14 1988 99 107